From: Immunostaining with D2–40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancer
Marker
All patients
SLN +
SLN -
pvalues*
VEGF-A a
Negative and weakly positive
37
13
24
0.32
Moderately positive
25
12
Strongly positive
30
6
MVD (CD34) b
79 (24–162)
79 (30–160)
81(24–162)
0.78
LVD (D2–40) b
7 (0–22)
8 (0–22)
7 (1–20)
0.73